Target Audience ▼
| This CME activity is intended and designed to educate pathologists. |
Accreditation ▼
| Physicians: Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Educational Symposia designates this enduring material for a maximum of 12.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All activity participants are required to take a written or online test in order to be awarded credit. (Exam materials, if ordered, will be sent with your order.) All course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives. AMA PRA Category 1 Credit(s)TM for these programs may be claimed until September 30, 2021. |
Topics
– Benign-borderline Lung Tumors
Mark R. Wick, M.D.
– Early Lung Carcinoma and Metastasis
Mark R. Wick, M.D.
– Mesothelioma IHC2
Mark R. Wick, M.D.
– Approach to Pulmonary Pathology Using Clinical, Radiological, and Pathological Correlation
Kevin O. Leslie, M.D.
– Guide to the WHO Adenocarcinoma Classification and Implications for Selection of Targeted Therapies
Kevin O. Leslie, M.D.
– Technical Issues in the Processing of Lung Samples
Kevin O. Leslie, M.D.
– Acute Lung Injury “One Ring to Rule Them All”
Kevin O. Leslie, M.D.
– The Pulmonary Pathology of Rheumatic Diseases
Kevin O. Leslie, M.D.
– Usual Interstitial Pneumonia of Idiopathic Pulmonary Fibrosis and its Mimics – Case Based
Maxwell L. Smith, M.D.
– Molecular Pathology of Lung Cancer – Case Based
Maxwell L. Smith, M.D.
– Granulomatous Disease of the Lung – Case Based
Kevin O. Leslie, M.D.
– Approach to Diffuse Alveolar Hemorrhage (DAH) and Pulmonary Vasculitis
Kevin O. Leslie, M.D.
– “Case Studies in Pulmonary Pathology 10 Diagnostic Vignettes …you should know
Kevin O. Leslie, M.D.
– Neoplastic Lung Disease – Case Based
Kevin O. Leslie, M.D.
– Practical Approach to Pulmonary Fibrosis
Kevin O. Leslie, M.D.
– Diagnosing Non-Small Cell Lung Carcinoma in the Molecular Age: Doing More With Less
Carol Farver, M.D.
– What’s New in the World Health Organization Classification of Lung Tumors
Carol Farver, M.D.
– Interstitial Lung Pathology: What Every Pathologist Needs to Know
Carol Farver, M.D.
CME Release Date 9/30/2018
CME Expiration Date 9/30/2021
